Bobak R. Azamian sold $801K of Tarsus Pharmaceuticals, Inc. (TARS) stock

Bobak R. Azamian, President/CEO and Board Chair of Tarsus Pharmaceuticals, Inc. (TARS), sold 10,000 shares of TARS stock worth $801K, per an SEC Form 4 filed Sep 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 2, 2026, 1 day before it was made public.

TARS has moved -6.9% since the trade date, from $82.76 to $77.08 (Sep 22, 2026 close).